On Thursday, CureVac N.V. (CVAC) remained one of the biggest gainers rising +16.51% to $101.19. To speed up the validation of its Covid-19 vaccine candidate and assist in its delivery, CureVac is collaborating with Germany’s Bayer.

DXC Technology Corporation (DXC) rose +9.3 percent to $28.91 on Wall Street. Atos (-13 percent in Paris!) has bid to buy its US rival DXC for more than $10 billion, according to Reuters reports. Atos is reportedly working on this proposed takeover of the former subsidiary of Hewlett Packard Enterprise with lawyers. Reportedly, the Frenchman had confronted the American earlier this week.

Albemarle Company (ALB) rose to $184, up +5.08 percent. To meet the anticipated demand for the metal used in light electric car batteries, Albemarle will double the output of lithium at its Nevada factory.

JPMorgan Chase & Co. (JPM) increased +3.28% to $135.87 whereas Wells Fargo & Company (WFC) rose to $33.43, up +2.26 percent. Jefferies, which has just elevated its recommendation from ‘hold’ to ‘buy’ on both banks, supports JP Morgan and Wells Fargo. The Democratic ‘blue wave’ is clearly inspiring the major investors of the place.

Constellation Brands, Inc. (STZ) increased to $228.87, up +2.3 percent. For the fiscal third quarter, Constellation Brands surpassed the analysts’ expectations. For the end-November period, the company posted quarterly net earnings of $1.28 billion or $6.55 per share, compared with $360 million a year ago. On an adjustment basis, earnings per share are $3.09.

Amazon.com, Inc. (AMZN) increased to $3162.16, up +0.76 percent. For third-party retailers, Amazon is temporarily easing the previously stated distribution rules. Due to coronavirus restrictions, CNBC states that Amazon told resellers of the logistics industry.

International Business Machines Corporation (IBM) declined by -0.23% to $128.99. The U.S. tech giant has announced that its previous CFO, Martin Schroeter, has been named as CEO of the new infrastructure management division.

LEAVE A REPLY

Please enter your comment!
Please enter your name here